$NikkoAM-STC Asia REIT(CFA.SI)$   Power of dividend! 🦾

$Micron Technology(MU)$  Earning meet expectations and forecast is good, how come the share price drop? 😩

$Guess?(GES)$ Guess Shares Surge 30% After WHP Global's $13-Per-Share Buyout Proposal

$Richtech Robotics(RR)$  up more than 30% single day. Crazy!!!!! 🦾

Based on recent news and economic data, it seems likely that the Fed will cut interest rates. In the stock market, which sectors benefit the most from rate cuts? I believe REITs and small-cap stocks will see the biggest gains. I’m preparing to invest heavily in Singapore REITs since their dividends are tax-free, unlike US stocks, where dividends are subject to taxation. This is just my personal opinion and forecast—no guarantees. Please do your own research before investing.

Adobe Inc. (NASDAQ: ADBE) is scheduled to release its fiscal first-quarter earnings report for 2025 after the market closes on March 12, 2025.  Analyst Expectations: • Earnings: The consensus among analysts is an adjusted earnings per share (EPS) of $4.97, representing an 11% increase year-over-year.  • Revenue: Projected revenue stands at $5.66 billion, a 9% rise compared to the same period last year.  Stock Performance and Analyst Ratings: As of March 12, 2025, Adobe’s stock is trading around $438 per share. The consensus price target is approximately $551, suggesting a potential 25% increase from current levels. Among 17 analysts tracked by Visible Alpha, 10 have rated the stock as a “buy,” six as “hold,” and one as “sell.”  Considerations: While Adobe has a history of meeting or ex

$Richtech Robotics(RR)$  recently AI stock down a lot

$Grab Holdings(GRAB)$   I just bought Grab stock for the long term. The company is expected to be profitable starting from next quarter. 😅🙏

$Guess?(GES)$ Predicting the future price of Guess? Inc. (GES) in 2025 is speculative: 1. Consumer Spending Trends 2. Brand and Product Innovation 3. Macroeconomic Factors 4. Operational Efficiency Speculative Prediction: • Bullish Case: If the company sustains growth initiatives and macro conditions improve, GES could trade in the $20–$25 range. • Neutral Case: With steady but unspectacular performance, the stock might hover around $15–$20. • Bearish Case: Significant challenges could see the stock dip below $12.

Here are several reasons why Elevance Health (ELV) stock could be considered a buy in 2025:  1. Medicare Advantage Growth  2.Strong Financial Fundamentals  3. Diverse Business Portfolio  4. Valuation and Recovery Potential  5. Strategic Initiatives  6. Favorable Industry Trends  Caution: While Elevance has growth potential, it’s essential to monitor regulatory changes, competitive pressures, and medical cost trends. Balancing these risks with its strengths can help in making an informed decision. Could go upwards movement in between 30%-60% 

With that in mind, I believe the upcoming earnings reports from Citigroup, Wells Fargo, Goldman Sachs, and JPMorgan could reflect resilience and adaptability, especially in a challenging economic climate. Higher interest rates might drive stronger net interest margins, and careful cost management could support steady performance. While challenges like credit quality and market volatility remain, I’m optimistic about their ability to navigate and deliver solid results, setting a confident tone for the broader earnings season.

Let’s go, team! 🚀 The 2025 Tiger Brokers Trading Challenge is our chance to shine. Stay focused, trade smart, and support each other every step of the way. Together, we can achieve great results. Believe in yourself and let’s make this challenge ours! 💪

Find out more here: 2025 Tiger Brokers Trade To Win Assemble your team and seize victory! ✌️ 

$Intel(INTC)$  Bought Intel

$Applied Materials(AMAT)$  Just brought 

$Fastly, Inc.(FSLY)$  Run first with little profit

$LION-PHILLIP S-REIT(CLR.SI)$  Fed finally cut rate. The best yet to come

$LION-PHILLIP S-REIT(CLR.SI)$  Chiong